LLY - Eli Lilly and Company

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue24,555,70022,871,30021,222,10019,958,700
Cost of Revenue6,397,2006,070,2005,654,9005,037,200
Gross Profit18,158,50016,801,10015,567,20014,921,500
Operating Expenses
Research Development5,307,1005,281,8005,243,9004,796,400
Selling General and Administrative6,631,8006,588,1006,452,0006,533,000
Non Recurring----
Others----
Total Operating Expenses18,336,10017,940,10017,350,80016,366,600
Operating Income or Loss6,219,6004,931,2003,871,3003,592,100
Income from Continuing Operations
Total Other Income/Expenses Net-2,423,900-2,733,800-497,300-802,100
Earnings Before Interest and Taxes6,219,6004,931,2003,871,3003,592,100
Interest Expense-110,800-225,000-185,200-161,200
Income Before Tax3,795,7002,197,4003,374,0002,790,000
Income Tax Expense563,7002,401,500636,400381,600
Minority Interest-75,70072,80019,000
Net Income From Continuing Ops3,232,000-204,1002,737,6002,408,400
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income3,232,000-204,1002,737,6002,408,400
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares3,232,000-204,1002,737,6002,408,400